farnesol and Disease Models, Animal

farnesol has been researched along with Disease Models, Animal in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.70)18.7374
1990's0 (0.00)18.2507
2000's17 (45.95)29.6817
2010's15 (40.54)24.3611
2020's4 (10.81)2.80

Authors

AuthorsStudies
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Choi, BO; Doo, HM; Hong, YB; Jang, SY; Kim, HJ; Kwak, G; Lee, YI; Park, NY1
Wang, X; Wang, Y; Yan, L; Zhao, L; Zhu, Y1
Chen, Y; Cheng, W; Dong, J; Jing, H; Liang, X; Liu, J; Shang, H; Wang, C; Wang, D; Wu, B; Yuan, Y; Zhou, Y1
Borges de Menezes Leite, L; Correa Amaral, A; Evangelista Araujo, D; Fernandes Costa, A; Pereira, M; Santos Cabral, M; Teles Brito, I1
Chang, HR; Huang, HH; Huang, YW; Kuo, SM; Wu, GX; Wu, KL1
Aizman, E; Chapman, J; Kloog, Y; Mor, A1
Aizman, E; Ben-Moshe, O; Blacher, E; Kloog, Y; Kogan, T; Mor, A1
Chen, Y; Huang, Y; Li, J; Li, S; Venkataramanan, R; Zhang, P; Zhang, X; Zhao, W1
Santhanasabapathy, R; Sudhandiran, G1
Anupriya, K; Pabitha, R; Santhanasabapathy, R; Sudhandiran, G; Vasudevan, S1
Bozó, A; Domán, M; Kardos, G; Kovács, R; Majoros, L; Varga, I1
Head, DD; Kotti, T; McKenna, CE; Russell, DW1
Bauer, V; Goldberg, L; Haklai, R; Heiss, A; Kloog, Y1
Alcudia, JF; Badimon, L; Guadall, A; Martínez-González, J; Raposo, B; Rodríguez, C; Sánchez-Gómez, S1
Cheporko, Y; George, J; Haklai, R; Hochhauser, E; Keren, G; Kloog, Y; Maysel-Auslender, S; Pando, R; Porat, E; Sagie, A1
Alam, MS; Athar, M; Chaudhary, SC; Siddiqui, MS1
Grafi-Cohen, M; Kloog, Y; Kraiem, Z; Levy, R1
Aizman, E; Assaf, Y; Chapman, J; Kloog, Y; Mor, A1
Aga-Mizrachi, S; Brunschwig, Z; Chapman, J; Dadush, O; Elad-Sfadia, G; Elbaz, M; Elmakayes, E; Ettinger, K; Haklai, R; Kloog, Y; Nevo, Y; Reif, S; Yanay, N1
Borbath, I; Stärkel, P1
Ben-Moshe, O; Haklai, R; Kloog, Y; Mekori, YA; Mor, A1
Abarca, J; Borbath, I; Charette, N; De Saeger, C; Horsmans, Y; Leclercq, I; Schneider-Merck, T; Stärkel, P1
Ishii, Y; Izumikawa, K; Kimura, S; Kohno, S; Ohno, A; Saga, T; Tashiro, M; Tashiro, T; Tateda, K; Yamaguchi, K1
Abranches, J; Bowen, WH; Cury, JA; Koo, H; Marquis, RE; Park, YK; Pearson, SK; Rosalen, PL; Scott-Anne, K1
Blank, M; Chapman, J; Katzav, A; Kloog, Y; Korczyn, AD; Molina, V; Shoenfeld, Y1
Alexandrovich, A; Biegon, A; Elad-Sfadia, G; Grossman, R; Haklai, R; Kloog, Y; Shohami, E; Yatsiv, I1
Barshack, I; Elad-Sfadia, G; George, J; Goldberg, I; Haklai, R; Keren, G; Keren, P; Kloog, Y; Sack, J1
Bottiglieri, T; Chin, PC; D'Mello, SR; Liu, L; Morrison, BE; Ratan, RR; Siddiq, A1
Chapman, J; Drory, V; Ferdman-Aronovich, R; Kafri, M; Katzav, A; Kloog, Y; Korczyn, AD; Wirguin, I1
Duhamel, GE; Hoerrmann, N; Hornby, JM; Navarathna, DH; Nickerson, KW; Parkhurst, AM1
Duhamel, GE; Hornby, JM; Krishnan, N; Navarathna, DH; Nickerson, KW; Parkhurst, A1
Duhamel, GE; Jerrels, TR; Navarathna, DH; Nickerson, KW; Petro, TM1
Alexandrovitch, A; Brandeis, R; Goelman, G; Kloog, Y; Marciano, D; Shohami, E1
De Leo, L; Decorti, G; Marcuzzi, A; Not, T; Pontillo, A; Tommasini, A; Ventura, A1
Afek, A; George, J; Goldberg, I; Haklai, R; Herz, I; Keren, G; Keren, P; Kloog, Y1
Ichiki, H; Isoda, M1

Reviews

1 review(s) available for farnesol and Disease Models, Animal

ArticleYear
Immunomodulatory properties of farnesoids: the new steroids?
    Current medicinal chemistry, 2013, Volume: 20, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Diabetes Mellitus, Type 2; Disease Models, Animal; Farnesol; Humans; Protein Binding; ras Proteins; Salicylates

2013

Other Studies

36 other study(ies) available for farnesol and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Farnesol Ameliorates Demyelinating Phenotype in a Cellular and Animal Model of Charcot-Marie-Tooth Disease Type 1A.
    Current issues in molecular biology, 2021, Nov-13, Volume: 43, Issue:3

    Topics: Animals; Biomarkers; Charcot-Marie-Tooth Disease; Demyelinating Diseases; Disease Models, Animal; Disease Susceptibility; Farnesol; Female; Gene Expression; Male; Mice; Myelin Proteins; Phenotype; Schwann Cells

2021
Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Doublecortin Protein; Extracellular Signal-Regulated MAP Kinases; Farnesol; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Maze Learning; Mice; Mice, Inbred ICR; Molecular Structure; Neuroprotective Agents; ras Proteins; Salicylates; Stereoisomerism

2019
Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma.
    Journal of nanobiotechnology, 2021, Jun-12, Volume: 19, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Diathermy; Disease Models, Animal; Endothelial Cells; Farnesol; Female; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; ras Proteins; Salicylates; Sequence Analysis, RNA

2021
Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Medical mycology, 2019, Jan-01, Volume: 57, Issue:1

    Topics: Animals; Antifungal Agents; BALB 3T3 Cells; Candida albicans; Candidiasis, Vulvovaginal; Capsules; Chitosan; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred BALB C; Miconazole; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles

2019
Antiaging and smoothness-improving properties of farnesol-based facial masks on rat skin exposed to ultraviolet B.
    Journal of cosmetic dermatology, 2020, Volume: 19, Issue:2

    Topics: Animals; Cell Line; Cosmeceuticals; Disease Models, Animal; Face; Farnesol; Female; Fibroblasts; Gels; Humans; Hyaluronic Acid; Hypromellose Derivatives; Mice; Rats; Skin; Skin Aging; Sunburn; Ultraviolet Rays

2020
Therapeutic effect of farnesylthiosalicylic acid on adjuvant-induced arthritis through suppressed release of inflammatory cytokines.
    Clinical and experimental immunology, 2014, Volume: 175, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cytokines; Disease Models, Animal; Farnesol; Inflammation Mediators; Joints; Male; ras GTPase-Activating Proteins; Rats; Salicylates; Signal Transduction; T-Lymphocyte Subsets

2014
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
    Molecular pharmaceutics, 2014, Aug-04, Volume: 11, Issue:8

    Topics: Animals; Breast Neoplasms; Disease Models, Animal; Drug Carriers; Farnesol; Female; HCT116 Cells; Hemolysis; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Salicylates

2014
Farnesol attenuates lipopolysaccharide-induced neurodegeneration in Swiss albino mice by regulating intrinsic apoptotic cascade.
    Brain research, 2015, Sep-16, Volume: 1620

    Topics: Animals; Antioxidants; Apoptosis; CA1 Region, Hippocampal; Cerebral Cortex; Disease Models, Animal; Escherichia coli; Farnesol; Lipopolysaccharides; Male; Mice; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Random Allocation

2015
Farnesol quells oxidative stress, reactive gliosis and inflammation during acrylamide-induced neurotoxicity: Behavioral and biochemical evidence.
    Neuroscience, 2015, Nov-12, Volume: 308

    Topics: Acrylamide; Animals; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Farnesol; Gliosis; Hippocampus; Interleukin-1beta; Lipid Peroxidation; Male; Mice; Movement Disorders; Neurodegenerative Diseases; Neuroimmunomodulation; Neuroprotective Agents; Oxidative Stress; Tumor Necrosis Factor-alpha

2015
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Journal of microbiology (Seoul, Korea), 2016, Volume: 54, Issue:11

    Topics: Animals; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Farnesol; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Quorum Sensing; Vagina; Virulence; Vulvovaginitis

2016
Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Aug-12, Volume: 105, Issue:32

    Topics: Alkyl and Aryl Transferases; Animals; Apolipoproteins E; Cholesterol; Cholesterol 24-Hydroxylase; Dendrites; Disease Models, Animal; Diterpenes; Farnesol; Hippocampus; Hyperlipoproteinemia Type III; Learning; Long-Term Potentiation; Mevalonic Acid; Mice; Mice, Knockout; Prenylation; Steroid Hydroxylases; Time Factors; Transferases

2008
New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Journal of medicinal chemistry, 2009, Jan-08, Volume: 52, Issue:1

    Topics: Amides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Farnesol; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Structure; Neoplasms; Oncogene Protein p21(ras); Salicylates; Xenograft Model Antitumor Assays

2009
Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Cardiovascular research, 2009, Aug-01, Volume: 83, Issue:3

    Topics: Animals; Atherosclerosis; Atorvastatin; Capillary Permeability; Cattle; Cells, Cultured; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Farnesol; Female; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, LDL; Protein Kinase C; Protein Kinase Inhibitors; Protein-Lysine 6-Oxidase; Pyrroles; rho-Associated Kinases; rhoA GTP-Binding Protein; Risk Factors; RNA, Messenger; Simvastatin; Swine; Transfection; Tumor Necrosis Factor-alpha

2009
Ras inhibition attenuates myocardial ischemia-reperfusion injury.
    Biochemical pharmacology, 2009, May-15, Volume: 77, Issue:10

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Farnesol; Heart Function Tests; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; ras Proteins; Rats; Rats, Inbred Lew; Rats, Wistar; Salicylates

2009
Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.
    Life sciences, 2009, Jul-31, Volume: 85, Issue:5-6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Chemoprevention; Cyclooxygenase 2; Disease Models, Animal; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Farnesol; Inflammation; Mice; Ornithine Decarboxylase; Oxidative Stress; ras Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate

2009
Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:8

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Farnesol; Galectin 3; Gene Expression Regulation, Neoplastic; Guanosine Triphosphate; Humans; Mice; Nuclear Proteins; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Salicylates; Signal Transduction; Thyroid Neoplasms; Thyroid Nuclear Factor 1; Transcription Factors; Xenograft Model Antitumor Assays

2010
The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice.
    Journal of neuroimmunology, 2010, Dec-15, Volume: 229, Issue:1-2

    Topics: Animals; Carrier Proteins; CD3 Complex; Cell Proliferation; Cytokines; Demyelinating Diseases; Disease Models, Animal; DNA Helicases; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Farnesol; Female; Forkhead Transcription Factors; Glatiramer Acetate; Immunosuppressive Agents; Leukemic Infiltration; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Peptides; Poly-ADP-Ribose Binding Proteins; RNA Helicases; RNA Recognition Motif Proteins; Salicylates; Spinal Cord; Spleen; Statistics, Nonparametric; Time Factors

2010
The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy.
    PloS one, 2011, Mar-22, Volume: 6, Issue:3

    Topics: Animals; Base Sequence; Blotting, Western; Disease Models, Animal; DNA Primers; Farnesol; Fibrosis; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Muscle Strength; Muscular Dystrophies; ras Proteins; Salicylates

2011
Chemoprevention of hepatocellular carcinoma. Proof of concept in animal models.
    Acta gastro-enterologica Belgica, 2011, Volume: 74, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Farnesol; Humans; Hypoglycemic Agents; Liver Neoplasms; Peptides, Cyclic; Pioglitazone; Salicylates; Somatostatin; Thiazolidinediones

2011
Inhibition of contact sensitivity by farnesylthiosalicylic acid-amide, a potential Rap1 inhibitor.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:10

    Topics: Amides; Animals; Cell Membrane; Disease Models, Animal; Farnesol; Female; Green Fluorescent Proteins; Guanosine Triphosphate; Humans; Immunohistochemistry; Jurkat Cells; Lymphocytes; Mice; Mice, Inbred BALB C; Phospholipase D; rap1 GTP-Binding Proteins; ras Proteins; Salicylates; Shelterin Complex; Skin; T-Lymphocytes; Telomere-Binding Proteins; Tumor Necrosis Factor-alpha

2011
Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
    Molecular carcinogenesis, 2012, Volume: 51, Issue:10

    Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cell Cycle; Cell Proliferation; Cyclin D; Diethylnitrosamine; Disease Models, Animal; Down-Regulation; Farnesol; Inflammation; Liver Neoplasms, Experimental; Male; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-myc; ras Proteins; Rats; Rats, Wistar; Salicylates; STAT3 Transcription Factor

2012
Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis.
    Medical mycology, 2012, Volume: 50, Issue:4

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Farnesol; Female; Mice; Mice, Inbred C3H; Pravastatin; Survival Analysis; Virulence Factors

2012
Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in rats.
    Oral microbiology and immunology, 2002, Volume: 17, Issue:6

    Topics: Analysis of Variance; Animals; Anti-Infective Agents, Local; Apigenin; Biofilms; Cariostatic Agents; Chlorhexidine; Dental Caries; Dental Deposits; Disease Models, Animal; Durapatite; Enzyme Inhibitors; Farnesol; Flavonoids; Fluorides; Glucosyltransferases; Random Allocation; Rats; Rats, Sprague-Dawley; Saliva; Statistics as Topic; Streptococcus milleri Group; Streptococcus mutans; Streptococcus sobrinus

2002
Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
    Immunobiology, 2003, Volume: 207, Issue:1

    Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Farnesol; Female; Freund's Adjuvant; Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; ras Proteins; Salicylates; Time Factors

2003
The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2003, Volume: 23, Issue:6

    Topics: Animals; Brain Injuries; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Guanosine Triphosphate; Head Injuries, Closed; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neuroprotective Agents; ras Proteins; Receptors, N-Methyl-D-Aspartate; Recovery of Function; Salicylates

2003
Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:2

    Topics: Animals; Carotid Artery Injuries; Carotid Artery, Common; Cell Division; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Enzyme Activation; Farnesol; GTP-Binding Proteins; Immunohistochemistry; Interferon-gamma; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; ras Proteins; Rats; Rats, Wistar; Salicylates; Spleen; Tunica Intima

2004
The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism.
    Journal of neurochemistry, 2004, Volume: 90, Issue:3

    Topics: Animals; Cell Death; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Huntington Disease; Indoles; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Phenols; Propionates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Salicylates; Signal Transduction

2004
Inhibition of Ras attenuates the course of experimental autoimmune neuritis.
    Journal of neuroimmunology, 2005, Volume: 168, Issue:1-2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Body Weight; Cell Proliferation; Cells, Cultured; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Immunologic; Drug Interactions; Electromyography; Enzyme Inhibitors; Farnesol; Female; Lymphocytes; Motor Activity; Mycobacterium tuberculosis; Myelin Proteins; Neural Conduction; Neuritis, Autoimmune, Experimental; ras Proteins; Rats; Rats, Inbred Lew; Rotarod Performance Test; Salicylates; Severity of Illness Index

2005
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:6

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; Farnesol; Fluconazole; Gas Chromatography-Mass Spectrometry; Mice; Microbial Sensitivity Tests; Survival Analysis; Virulence

2005
Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
    Infection and immunity, 2007, Volume: 75, Issue:4

    Topics: Animals; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Farnesol; Female; Gene Deletion; Genes, Fungal; Kidney; Mice; Virulence Factors

2007
Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.
    Infection and immunity, 2007, Volume: 75, Issue:8

    Topics: Animals; Candida albicans; Candidiasis; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Farnesol; Female; Flow Cytometry; Macrophages, Peritoneal; Mice; Virulence Factors

2007
Neuroprotective effects of the Ras inhibitor S-trans-trans-farnesylthiosalicylic acid, measured by diffusion-weighted imaging after traumatic brain injury in rats.
    Journal of neurotrauma, 2007, Volume: 24, Issue:8

    Topics: Animals; Brain Injuries; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Farnesol; Male; Motor Activity; ras Proteins; Rats; Recovery of Function; Salicylates; Time Factors

2007
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency.
    Pediatric research, 2008, Volume: 64, Issue:2

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Acyclic Monoterpenes; Alendronate; Animals; Disease Models, Animal; Diterpenes; Farnesol; Inflammation; Male; Mevalonate Kinase Deficiency; Mice; Mice, Inbred BALB C; Terpenes

2008
Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.
    Circulation, 2002, May-21, Volume: 105, Issue:20

    Topics: Animals; Aorta; Apolipoproteins E; Arteriosclerosis; Autoantibodies; Cell Division; Cells, Cultured; Cholesterol; Dietary Fats; Disease Models, Animal; Enzyme Inhibitors; Farnesol; Injections, Intraperitoneal; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; ras Proteins; Salicylates; Spleen; Treatment Outcome; Triglycerides; Vascular Cell Adhesion Molecule-1

2002
The Mann-Williamson ulcer as a model for testing antiulcer drugs. Results obtained with gefarnate.
    Arzneimittel-Forschung, 1973, Volume: 23, Issue:3

    Topics: Animals; Disease Models, Animal; Dogs; Enteritis; Farnesol; Fatty Acids, Unsaturated; Plants, Medicinal; Stomach Ulcer; Terpenes

1973